What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.76%
Annual Rate
CNY 0.05Paid semi-annual
Payout Ratio
27.8%Sustainable
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
17.07BCNY
2.53B · vs all stocks (USD)
Updated Jul 25, 2026
Trailing P/E
37.37x
Updated Jul 25, 2026
Revenue (TTM)
4.76BCNY
704.79M · vs all stocks (USD)
Updated Jul 25, 2026
Profit Margin
9.47%
Updated Jul 25, 2026
Beta
0.3820x
vs all stocks
Updated Jul 25, 2026
52-Week Change
-7.91%
vs all stocks
Updated Jul 25, 2026
Forward Annual Dividend Yield
0.76%
vs all stocks
Updated Jul 25, 2026
Market Capitalization
17.07BCNY
2.53B · vs all stocks (USD)
Updated Jul 25, 2026
Enterprise Value
57.37BCNY
8.50B · vs all stocks (USD)
Updated Jul 25, 2026
Trailing P/E
37.37x
Updated Jul 25, 2026
Price to Sales (TTM)
3.59x
Updated Jul 25, 2026
Price to Book (MRQ)
1.33x
Updated Jul 25, 2026
Enterprise to Revenue
12.06x
Updated Jul 25, 2026
Enterprise to EBITDA
13.74x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 40.66×.Updated Jul 25, 2026
Gross Margin
27.03%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 37.79%.Updated Jul 25, 2026
Profit Margin
9.47%
Updated Jul 25, 2026
Operating Margin
17.19%
Updated Jul 25, 2026
Return on Assets (TTM)
1.62%
Updated Jul 25, 2026
Return on Equity (TTM)
3.44%
Updated Jul 25, 2026
Revenue (TTM)
4.76BCNY
704.79M · vs all stocks (USD)
Updated Jul 25, 2026
Revenue per Share (TTM)
1.98CNYUpdated Jul 25, 2026
Quarterly Revenue Growth
-10.70%
Updated Jul 25, 2026
Gross Profit (TTM)
1.80BCNY
266.32M · vs all stocks (USD)
Updated Jul 25, 2026
EBITDA (TTM)
1.41BCNY
209.03M · vs all stocks (USD)
Updated Jul 25, 2026
Net Income (TTM)
450.40MCNY
66.73M · vs all stocks (USD)
Updated Jul 25, 2026
Quarterly Earnings Growth (YoY)
-66.20%
Updated Jul 25, 2026
Operating Cash Flow (TTM)
4.42BCNY
654.23M · vs all stocks (USD)
Updated Jul 25, 2026
Levered Free Cash Flow (TTM)
-153.44MCNY
-22.73M · vs all stocks (USD)
Updated Jul 25, 2026
Forward Annual Dividend Rate
0.0540CNYUpdated Jul 25, 2026
Forward Annual Dividend Yield
0.76%
vs all stocks
Updated Jul 25, 2026
Trailing Annual Dividend Rate
0.0640CNYUpdated Jul 25, 2026
Trailing Annual Dividend Yield
0.90%
vs all stocks
Updated Jul 25, 2026
Payout Ratio
27.76%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 33.68%.Updated Jul 25, 2026
Minority Interest (Equity)
6.67BCNYFY2025 · Dec 31, 2025
Revenue
4.88BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.93BCNYFY2025 · Dec 31, 2025
Gross Profit
1.94BCNYFY2025 · Dec 31, 2025
Operating Income
1.58BCNY
234.04M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
910.78MCNYFY2025 · Dec 31, 2025
Income Tax Expense
162.61MCNYFY2025 · Dec 31, 2025
Net Income
748.17MCNYFY2025 · Dec 31, 2025
EBIT
1.88BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
4.18BCNYFY2025 · Dec 31, 2025
Research & Development
11.79MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
65.02MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
76.67MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
6.91MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
969.69MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.2104CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.2104CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.40BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.40BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
748.17MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-242.24MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
2.30BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-383.00MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
2.31BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
748.17MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
973.07MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
605.94MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-30.68MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-2.68BCNYFY2025 · Dec 31, 2025
Net Acquisitions
-6.27MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-457.24MCNYFY2025 · Dec 31, 2025
Sale of Investments
225.12MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-51.41MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.97BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
7.65BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-7.45BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-990.95MCNYFY2025 · Dec 31, 2025
Other Financing Charges
111.73MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-677.65MCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.40BSharesUpdated Jul 25, 2026
Float Shares
447.41MSharesUpdated Jul 25, 2026
% Held by Insiders
81.74%
vs all stocks
Updated Jul 25, 2026
% Held by Institutions
2.40%
vs all stocks
Updated Jul 25, 2026
Total Cash (MRQ)
1.93BCNY
285.33M · vs all stocks (USD)
Updated Jul 25, 2026
Total Cash per Share (MRQ)
0.8010CNYUpdated Jul 25, 2026
Total Debt (MRQ)
35.57BCNY
5.27B · vs all stocks (USD)
Updated Jul 25, 2026
Total Debt to Equity (MRQ)
1.82x
Updated Jul 25, 2026
Current Ratio (MRQ)
1.42x
Updated Jul 25, 2026
Book Value per Share (MRQ)
5.34CNYUpdated Jul 25, 2026
Total Assets
58.66BCNY
8.69B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
11.87BCNYFY2025 · Dec 31, 2025
Total Liabilities
39.18BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
46.79BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
29.78BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
9.39BCNYFY2025 · Dec 31, 2025
Cash
2.59BCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.32MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.59BCNYFY2025 · Dec 31, 2025
Accounts Receivable
8.21BCNYFY2025 · Dec 31, 2025
Inventory
10.04MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.42BCNYFY2025 · Dec 31, 2025
Short-term Debt
6.23BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
797.05MCNYFY2025 · Dec 31, 2025
Long-term Debt
27.12BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
26.78MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.40BCNYFY2025 · Dec 31, 2025
Retained Earnings
3.17BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
19.48BCNY
2.89B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
6.30CNYUpdated Jul 25, 2026
52-Week High
14.10CNYUpdated Jul 25, 2026
52-Week Change
-7.91%
vs all stocks
Updated Jul 25, 2026
Beta
0.3820x
vs all stocks
Updated Jul 25, 2026
50-Day MA
8.53CNYUpdated Jul 25, 2026
200-Day MA
8.49CNYUpdated Jul 25, 2026
Avg 10-Day Volume
52.57MSharesUpdated Jul 25, 2026
Avg 30-Day Volume
41.86MSharesUpdated Jul 25, 2026
Diluted EPS (TTM)
0.1900CNYUpdated Jul 25, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.58: distress zoneCritical
Altman Z-Score: 0.58
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Market cap is $2.53B, above the global median of $1.15BNotable
Market cap (USD): 2,529,564,541.568Global Median: 1,146,734,693.424
Revenue is $704.79M, above the global median of $520.53MNotable